Interestingly, liver inflammation and fibrosis further affect the LSEC molecular phenotype, leading to downregulation of LYVE-1 in liver cancer and cirrhosis [73], and of FcγRIIb in non-alcoholic steatohepatitis [74]. The gene discussed is LYVE1; the disease is liver cancer.